Nucleocapsid Antigenemia in Patients Receiving Anti-CD20 Therapy With Protracted COVID-19

Immunocompromised patients with prolonged coronavirus disease 2019 symptoms present diagnostic and therapeutic challenges. We measured viral nucleocapsid antigenemia in 3 patients treated with anti-CD20 immunotherapy who acquired severe acute respiratory syndrome coronavirus 2 infection and experien...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilber, Eli, Piantadosi, Anne, Babiker, Ahmed, McLendon, Kaleb, O’Sick, William, Fitts, Eric, Webster, Andrew S, Verkerke, Hans, Kim, James S, Phadke, Varun K, Rouphael, Nadine, Titanji, Boghuma K, Blake, William T, Howard-Anderson, Jessica, Roback, John D, Lam, Wilbur A, Damhorst, Gregory L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416058/
https://www.ncbi.nlm.nih.gov/pubmed/36043176
http://dx.doi.org/10.1093/ofid/ofac419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416058/
https://www.ncbi.nlm.nih.gov/pubmed/36043176
http://dx.doi.org/10.1093/ofid/ofac419

Ejemplares similares